Versão em português

FAPESP and GSK announce result of call for proposals

FAPESP and GSK announce result of call for proposals

Three research projects were selected and will be funded up to 24 months (GSK)

FAPESP and GlaxoSmithKline (GSK) make public the result of a call for proposals opened in July, 2013 in the following topics: Metabolic Diseases; Tropical and Neglected Diseases; Infectious Diseases; Respiratory Diseases; Inflammation and Immunology; Biopharmaceuticals and Vaccines.

The total amount available for this call for proposals is US$ 600.000, with a maximum of US$ 200.000 per project.

The duration of selected projects will be of up to 24 months.

Selected proposals: 

Researchers Project title
Paula Rahal
Instituto de Biociências, Letras e Ciências Exatas (IBILCE), UNESP

Therapeutic potential of Flavonoid-like Drugs on Hepatitis C Virus Infection
FAPESP #: 2013/50678-3

Arlene Gonçalves Correa
Centro de Ciências Exatas e de Tecnologia (CCET), UFSCAR

Quinoxaline derivatives as antiparasitic drugs:proof of concept
FAPESP#: 2013/50680-8

Flavio da Silva Emery
Faculdade de Ciências Farmacêuticas de Ribeirão Preto (FCFRP), USP

Exploring epigenetic targets to fight neglected diseases: Selective sirtuin-2 inhibitors as leishmanicidal compounds
FAPESP#: 2013/50677-7

The call for proposals is available at: www.fapesp.br/en/7858.